Sign in

CIK 0001070494 · Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
061376651
Phone
858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Open-market sale EVP, COO, HEAD OF COMMERCIAL sold 10,329 shares at $16.81 ($173,630)
  2. 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 4,073 shares at $16.81 ($68,467)
  3. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 10,259 shares at $16.81 ($172,454)
  4. 4 Option exercise Director acquired 4,381 shares (option exercise)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 9,733 shares at $15.28 ($148,720)
  8. 4 Open-market sale EVP, COO, HEAD OF COMMERCIAL sold 9,534 shares at $15.28 ($145,680)
  9. 4 Open-market sale CEO sold 31,747 shares at $15.28 ($485,094)
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 975 shares at $14.79 ($14,420)
  12. 4 Option exercise Director acquired 6,652 shares (option exercise)
  13. 4 Option exercise Director acquired 6,652 shares (option exercise)
  14. 4 Option exercise Director acquired 6,652 shares (option exercise)
  15. 4 Option exercise Director acquired 6,652 shares (option exercise)
  16. 4 Option exercise Director acquired 6,652 shares (option exercise)
  17. 4 Option exercise Director acquired 6,652 shares (option exercise)
  18. 4 Grant or award Director acquired 37,548 shares (grant or award)
  19. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 3,503 shares at $16.94 ($59,341)
  20. 4 Open-market sale EVP, COO, HEAD OF COMMERCIAL sold 3,477 shares at $16.94 ($58,900)

Page 4 of 35 · 686 filings